Inventor · disambiguated record
Daren R. Ure
Also filed as: URE DAREN · URE DAREN R · URE DAREN RAYMOND
6 granted patents·14 pending applications·155 citations·filing 2001–2025
84Inventor score
Files withHEPION PHARMACEUTICALS INC9MAYO FOUNDATION3PEASE LARRY R3CONTRAVIR PHARMACEUTICALS INC2HEGMANS ALEXANDER1
Top patents by PatentIndex Score
20 records- 0195US7390888B2Dendritic cell potentiationMAYO FOUNDATION·Filed 2005·Granted Jun 24, 2008·37 cites·3 claims
- 0292US7052694B2Dendritic cell potentiationMAYO FOUNDATION·Filed 2002·Granted May 30, 2006·47 cites·21 claims
- 0392US6800285B2Treatment of central nervous system diseases by antibodies against glatiramer acetateFiled 2001·Granted Oct 5, 2004·60 cites·14 claims
- 0478US9200038B2Cyclosporine analogue molecules modified at amino acid 1 and 3HEGMANS ALEXANDER·Filed 2011·Granted Dec 1, 2015·11 cites·28 claims
- 0575US2010009438A1Dendritic cell potentiationPEASE LARRY R·Filed 2009·Application pending·0 cites
- 0669US2023390199A1Generating a microemulsion formation with improved solubilityHEPION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0769US2023390198A1Forming a self-microemulsifying drug delivery systemHEPION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0866US2010015163A1Dendritic cell potentiationPEASE LARRY R·Filed 2009·Application pending·0 cites
- 0965US2008193467A1Dendritic cell potentiationPEASE LARRY R·Filed 2008·Application pending·0 cites
- 1064US2025057807A1Treating a disease using a pharmaceutically active ingredient present in a pseudo-ternary phase systemHEPION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1164US2023398174A1Pseudo-ternary phase system for improving solubility of a pharmaceutically active ingredientHEPION PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1261US2020163876A1Pharmaceutical formulations of cyclosporine analogsHEPION PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1360US2025360181A1Use of cyclosporine analogues for treating fibrosisHEPION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1456US2011065178A1Dendritic cell potentiationMAYO FOUNDATION·Filed 2010·Application pending·0 cites
- 1555US12409206B2Use of cyclosporine analogues for treating fibrosisHEPION PHARMACEUTICALS INC·Filed 2021·Granted Sep 9, 2025·0 cites·19 claims
- 1650US2005019322A1Treatment of central nervous system diseases by antibodies against glatiramer acetateFiled 2004·Application pending·0 cites
- 1745US2022168385A1Use of cyclosporine analogues as antithrombotic agentsHEPION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1840US2021269479A1Use of cyclosporine analogues for treating cancerHEPION PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1940US2018296588A1Combination therapy for treating viral infectionsCONTRAVIR PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2034US9714271B2Cyclosporine analogue molecules modified at amino acid 1 and 3CONTRAVIR PHARMACEUTICALS INC·Filed 2015·Granted Jul 25, 2017·0 cites·39 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →